Basic Information
Remarks
Chemical Identifiers
Basic Properties
Lipinski RO5
Hydrophobic Tag Properties
Mechanism of Action
POI (Protein of Interest)
Amino Acid Sequence
3D Structure (/structures/AF-P29373-F1-model_v6.cif)
Function
Transports retinoic acid to the nucleus. Regulates the access of retinoic acid to the nuclear retinoic acid receptors.
Degradation Pathway
Mechanism
The ubiquitin-proteasome pathway (UPP) constitutes the principal pathway for protein degradation in eukaryotic cells, mediating the breakdown of target proteins through ubiquitin tagging and subsequent proteasomal degradation. In an ATP-dependent manner, the ubiquitin-activating enzyme (E1) activates ubiquitin (Ub) and conjugates it to a ubiquitin-conjugating enzyme (E2). E3 ligase subsequently catalyzes the transfer of Ub to the target protein, leading to the formation of a polyubiquitin chain that completes the ubiquitination mark. The 19S regulatory particle of the 26S proteasome recognizes this ubiquitination signal and, after deubiquitination, mediates the ATP-dependent delivery of the substrate into the 20S proteasome for degradation.
Description
We also examined the involvement of the proteasome in HyT-mediated degradation. The 2 and 3-induced reductions of CRABP-2 were completely inhibited in the presence of the proteasome inhibitor MG132, suggesting that 2 and 3 induce the proteasomal degradation of CRABP-2 (Figure 4). This result clearly indicated the involvement of proteasome activity for the reduction of the target protein
Activity Data
Description
We examined the protein reduction activity of 2, 3, and 4 using various cell lines. In MCF-7 cells; 2 and 3 effectively reduced the CRABP-2 protein level, whereas 4, which contained the less hydrophobic benzyl moiety, showed attenuated protein knockdown activity (Figure 3A and Figure S5). The CRABP2 reduction activity of 3 was similar to that of 1 in MCF7 cells (Figure S6).
Disease Information
| Disease | ICD-11 | Source |
|---|---|---|
| Invasive breast carcinoma of no special type | 2C61.4 | Cell Line Origin |
| Embryonal Carcinoma | XH8MB9 | Gene-Disease Association |
| Hyperlipidemia, Familial Combined, 3 | 5C80.2 | Gene-Disease Association |
| Lung Cancer | 2C25.Z | Gene-Disease Association |
| Breast Cancer | 2C6Z | Gene-Disease Association |
| Ovarian Cancer | 2C73.Z | Gene-Disease Association |
| Leukemia, Acute Myeloid | 2A60.3Z | Gene-Disease Association |